Skip to main content

Table 2 Correlations of FOXP1 expression with the clinicopathological characteristics of ICC

From: Identification of FOXP1 as a favorable prognostic biomarker and tumor suppressor in intrahepatic cholangiocarcinoma

Clinicopathological characteristics

Case number(n)

FOXP1

Positive number (%)

Χ2

p

Age (years)

 ≥ 63

31

17(54.8)

0.013

0.908

 < 63

43

23(53.5)

  

Sex

 Male

34

21(61.8)

1.506

0.220

 Female

40

19(47.5)

  

Differentiation

 Moderately-well

48

31(64.6)

6.098

0.014

 Poorly

26

9(34.6)

  

Pathogeny

 Hepatitis

12

7(58.3)

0.853

0.356

 Stones

5

3(60.0)

  

 History of biliary surgery

4

3(75.0)

  

 Others

56

28(50.0)

  

Tumor size (cm)

 < 5

21

9(42.9)

1.480

0.224

 ≥ 5

53

31(58.5)

  

Lymph node metastasis

 Yes

29

10(34.5)

7.355

0.007

 No

45

30(66.7)

  

Invasion

 YES

21

7(33.3)

5.069

0.024

 No

53

33(66.3)

  

TNM Stages

 I-II

42

29(69.0)

8.792

0.003

 III

32

11(34.4)

  

Star lesion

 Yes

28

14(50.0)

0.298

0.585

 No

46

26(56.5)

  

Micronerve infiltration

 Yes

14

8(57.1)

0.066

0.797

 No

60

32(53.3)

  

Vessel invasion

 Yes

12

8(66.7)

0.917

0.338

 No

62

32(51.6)

 Â